20062017

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2017

Mutations targeting the coagulation pathway are enriched in brain metastases

Richichi, C., Fornasari, L., Melloni, G. E. M., Brescia, P., Patanè, M., Del Bene, M., Mustafa, D. A. M., Kros, J. M., Pollo, B., Pruneri, G., Sciandivasci, A., Munzone, E., Dimeco, F., Pelicci, P. G., Riva, L. & Pelicci, G., Dec 1 2017, In : Scientific Reports. 7, 1, 6573.

Research output: Contribution to journalArticle

Mutations targeting the coagulation pathway are enriched in brain metastases

Richichi, C., Fornasari, L., Melloni, G. E. M., Brescia, P., Patanè, M., Del Bene, M., Mustafa, D. A. M., Kros, J. M., Pollo, B., Pruneri, G., Sciandivasci, A., Munzone, E., Dimeco, F., Pelicci, P. G., Riva, L. & Pelicci, G., 2017, In : Scientific Reports. 7, 1

Research output: Contribution to journalArticle

2014
2013
2012
2008

Biweekly triple combination chemotherapy with gemcitabine, oxaliplatin, levofolinic acid and 5-fluorouracil (GOLF) is a safe and active treatment for patients with inoperable pancreatic cancer

Correale, P., Montagnani, F., Miano, S., Sciandivasci, A., Pascucci, A., Petrioli, R., Testi, W., Tanzini, G. & Francini, G., Feb 2008, In : Journal of Chemotherapy. 20, 1, p. 119-125 7 p.

Research output: Contribution to journalArticle

Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: A randomized study of two different schedules of oxaliplatin

Petrioli, R., Pascucci, A., Francini, E., Marsili, S., Sciandivasci, A., Tassi, R., Civitelli, S., Tanzini, G., Lorenzi, M. & Francini, G., Jan 2008, In : Cancer Chemotherapy and Pharmacology. 61, 1, p. 105-111 7 p.

Research output: Contribution to journalArticle

2007

Capecitabine as third-line treatment in patients with metastatic renal cell carcinoma after failing immunotherapy

Petrioli, R., Paolelli, L., Francini, E., Marsili, S., Pascucci, A., Sciandivasci, A., De Rubertis, G., Barbanti, G., Manganelli, A., Salvestrini, F. & Francini, G., Aug 2007, In : Anti-Cancer Drugs. 18, 7, p. 817-820 4 p.

Research output: Contribution to journalArticle

Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation

Correale, P., Sciandivasci, A., Intrivici, C., Pascucci, A., Del Vecchio, M. T., Marsili, S., Savelli, V., Voltolini, L., Di Bisceglie, M., Guarnieri, A., Gotti, G. & Francini, G., May 7 2007, In : British Journal of Cancer. 96, 9, p. 1343-1347 5 p.

Research output: Contribution to journalArticle

Weekly high-dose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxel

Petrioli, R., Pascucci, A., Francini, E., Marsili, S., Sciandivasci, A., De Rubertis, G., Barbanti, G., Manganelli, A., Salvestrini, F. & Francini, G., Oct 2007, In : BJU International. 100, 4, p. 775-779 5 p.

Research output: Contribution to journalArticle

2006

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients

Correale, P., Cerretani, D., Remondo, C., Martellucci, I., Marsili, S., La Placa, M., Sciandivasci, A., Paolelli, L., Pascucci, A., Rossi, M., Di Bisceglie, M., Giorgi, G., Gotti, G. & Francini, G., Jul 2006, In : Oncology Reports. 16, 1, p. 133-140 8 p.

Research output: Contribution to journalArticle